18.07.2012 | Symbiotics and Gonet & Cie collaborate on emerging sustainable fund

Symbiotics teams up with the private bank Gonet & Cie for the launch of its emerging sustainable fund

Symbiotics innovates in the field of sustainable investments by launching a multi-strategy fund of fund. This product offers to its investor base an access to the diverse activities and areas of expertise covered by the company, namely about 50 high growth emerging and frontier markets, with an exposure not only to microfinance and low income financial infrastructure more broadly (savings, insurance, leasing, mortgages, mobile banking, remittances), but also to SME finance, with a particular accent put on job creation and the development of access to goods and services of first necessity (access to food, homes and energy) whose demand largely exceed the current offer in these markets.

The private bank Gonet & Cie was seduced by this approach and decided to let a portion of its client base benefit from it. Serge Robin, partner of the bank in charge of Asset Management, comments: "It was important for us that such a concept, which materializes our conviction in terms of sustainable development, proved its solidity in terms of risk and return, which seems to be the case in light of the results and performance over the past decade. Additionally, the decorrelation which it induces compared to traditional asset classes in case of stress on the capital markets legitimates the product in our investment philosophy. We thus think that such an investment strategy will create value for our clients, by balancing and diversifying their portfolios in the current difficult environment. We look forward to seeing this strategy unfold and to collaborate with Symbiotics." The reference index of the fund is the SMX MIV Debt index which since its launch in 2003 has generated on average 3.98% net return per annum in USD, with a volatility of 0.61%.

This sector of investment is relatively recent, in the sense that it cumulates the benefits of high economic growth markets, offering many value creation and capital gain opportunities, and the discipline of a sustainable and socially responsible approach, which seeks to take into account the interest of the various stakeholders involved in its value chain in order to generate stable long term development in underserved economies. It consequently offers a double added-value for the wealth management industry. It is nevertheless restricted to professional qualified investors, not being traded on regulated and liquid markets. With today about USD 25 billion of foreign direct investments and a growth of about 30% per annum over the past decade, this sector should gradually open itself to a larger universe of investors and asset managers.

For Roland Dominicé, CEO of Symbiotics, « We are happy to be able to bring our emerging market and sustainable investment expertise to the private bank Gonet & Cie and are convinced of the well-founded value of this investment proposal for their clientele. Today's investors can only benefit from innovative expertise and strategies which allow them to access high growth markets and reduce the challenge with they are facing in the current global market environment."

 

 

About Symbiotics S.A. :
Symbiotics is an investment company specialized in microfinance and SME financing in emerging markets. The company is the leading investment research and advisory firm in the sector and one of its principal specialized fund managers. Symbiotics has invested, on behalf of over 20 specialized investment funds, over USD 1 billion in more than 150 financial institutions in about 50 emerging and frontier markets. The company was created in 2004 in Geneva, where it is based, with regional offices in Cape Town, Mexico City and Singapore, employing today over 40 investment professionals.

For more information :
Claire Dorey, Communication Officer
Claire.Dorey@symbioticsgroup.com
+41 22 338 15 40
www.symbioticsgroup.com

About Gonet & Cie - Banquiers Privés :
The Gonet Group is present in Geneva, Lausanne, Nassau and Singapore. Gonet & Cie - Banquiers Privés, whose origins go back to 1845, offers global wealth management services to a Swiss and international.  Gonet & Cie is a member of the Swiss Bankers Association (ASB) and part of the 12 members of the Swiss Private Bankers Association (ABPS).

Pour plus d'information :
www.gonet.ch

 

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree